GlassScriptPhysician profile
Yuliya Kats
NPI 1558419598
$1,381.84
in general payments reported to CMS, 2019-2025
17 companies · $26.45 in 2025
The $26.45 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $278 · 2020: $146 · 2021: $196 · 2022: $213 · 2023: $436 · 2024: $86.08 · 2025: $26.45.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $549.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $548.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $297.00 | 2022-2023 | Sapien 3 Ultra Resilia |
| Abbott Laboratories | $267.44 | 2019-2020 | |
| Boston Scientific Corporation | $226.67 | 2021-2023 | Watchman |
| Novartis Pharmaceuticals Corporation | $112.40 | 2019 | |
| Daiichi Sankyo INC. | $70.97 | 2023-2024 | Injectafer |
| Philips North America LLC | $65.44 | 2022-2023 | |
| Amgen INC. | $56.81 | 2020-2021 | |
| Inspire Medical Systems, INC. | $56.36 | 2023-2024 | Inspire |
| Merck Sharp & Dohme LLC | $43.23 | 2023 | Verquvo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $33.21 | 2023 | Jardiance |
| Alnylam Pharmaceuticals INC. | $29.90 | 2022-2023 | Onpattro |
| E.R. Squibb & Sons, L.L.C. | $28.57 | 2021-2023 | Camzyos |
| Atricure, INC. | $26.45 | 2025 | Epi-Sense Guided Coagulation System With Visitrax, Atriclip Laa Exclusion System |
| Nabriva Therapeutics, Plc | $20.33 | 2021 | |
| Lexicon Pharmaceuticals, INC. | $17.19 | 2023 | Inpefa |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $15.00 | 2019 | |
| Amarin Pharma, INC. | $14.87 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yuliya Kats listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.